O	0	8	Clinical
O	9	14	study
O	15	17	of
O	18	26	combined
O	27	38	application
O	39	41	of
B-intervention	42	53	indocyanine
I-intervention	54	59	green
I-intervention	60	63	and
I-intervention	64	73	methylene
I-intervention	74	78	blue
O	79	82	for
O	83	91	sentinel
O	92	97	lymph
O	98	102	node
O	103	109	biopsy
O	110	112	in
O	113	119	breast
O	120	126	cancer
O	126	127	.

O	128	132	This
O	133	138	study
O	139	143	aims
O	144	146	to
O	147	158	investigate
O	159	162	the
O	163	174	feasibility
O	175	177	of
O	178	186	combined
O	187	198	application
O	199	201	of
O	202	213	indocyanine
O	214	219	green
O	220	221	(
O	221	224	ICG
O	224	225	)
O	226	229	and
O	230	239	methylene
O	240	244	blue
O	245	246	(
O	246	248	MB
O	248	249	)
O	250	253	for
O	254	262	sentinel
O	263	268	lymph
O	269	273	node
O	274	280	biopsy
O	281	282	(
O	282	286	SLNB
O	286	287	)
O	288	290	in
O	291	299	patients
O	300	304	with
O	305	310	early
O	311	317	breast
O	318	324	cancer
O	324	325	.

O	326	327	A
O	328	333	total
O	334	336	of
B-total-participants	337	340	415
B-eligibility	341	349	patients
I-eligibility	350	353	who
I-eligibility	354	363	underwent
I-eligibility	364	368	SLNB
I-eligibility	369	372	and
I-eligibility	373	381	axillary
I-eligibility	382	387	lymph
I-eligibility	388	392	node
I-eligibility	393	403	dissection
O	404	408	were
O	409	417	enrolled
O	417	418	.

O	419	427	Sentinel
O	428	433	lymph
O	434	438	node
O	439	440	(
O	440	443	SLN
O	443	444	)
O	445	448	was
O	449	457	assessed
O	458	460	in
B-intervention-participants	461	464	197
O	465	473	patients
O	474	478	with
O	479	482	ICG
O	483	486	and
O	487	489	MB
O	490	501	combination
O	502	508	method
O	508	509	,
O	510	515	while
O	515	516	,
O	517	520	the
O	521	526	other
B-control-participants	527	530	218
O	531	539	patients
O	540	544	were
O	545	553	detected
O	554	556	by
B-control	557	559	MB
I-control	560	566	method
I-control	567	572	alone
O	572	573	.

O	574	580	During
O	581	588	surgery
O	588	589	,
O	590	593	all
O	594	598	SLNs
O	599	603	were
O	604	613	harvested
O	614	617	for
O	618	630	pathological
O	631	642	examination
O	642	643	.

O	644	648	Then
O	649	652	the
B-outcome	653	662	detection
I-outcome	663	667	rate
I-outcome	668	671	and
I-outcome	672	677	false
I-outcome	678	686	negative
I-outcome	687	691	rate
I-outcome	692	694	of
I-outcome	695	699	SLNs
O	700	704	were
O	705	718	comparatively
O	719	727	analyzed
O	728	735	between
O	736	739	the
O	740	741	2
O	742	748	groups
O	748	749	.

O	750	752	In
O	753	756	the
O	757	765	combined
O	766	769	ICG
O	770	773	and
O	774	776	MB
O	777	782	group
O	782	783	,
O	784	787	the
B-outcome	788	797	detection
I-outcome	798	802	rate
I-outcome	803	805	of
I-outcome	806	810	SLNs
O	811	814	was
B-iv-bin-percent	815	817	96
I-iv-bin-percent	817	818	.
I-iv-bin-percent	818	819	9
I-iv-bin-percent	819	820	%
O	820	821	,
O	822	835	significantly
O	836	842	higher
O	843	847	than
O	848	852	that
O	853	855	of
O	856	858	MB
O	859	864	group
O	864	865	,
O	866	871	which
O	872	875	was
B-cv-bin-percent	876	878	89
I-cv-bin-percent	878	879	.
I-cv-bin-percent	879	880	7
I-cv-bin-percent	880	881	%
O	882	883	(
O	883	884	P
O	885	886	<
O	887	888	.
O	888	890	05
O	890	891	)
O	891	892	.

O	893	902	Similarly
O	902	903	,
O	904	906	in
O	907	915	combined
O	916	921	group
O	921	922	,
O	923	926	the
B-outcome	927	934	average
I-outcome	935	941	number
I-outcome	942	944	of
I-outcome	945	949	SLNs
I-outcome	950	953	per
I-outcome	954	961	patient
O	962	965	was
B-iv-cont-mean	966	967	3
I-iv-cont-mean	967	968	.
I-iv-cont-mean	968	969	0
O	969	970	,
O	971	975	much
O	976	982	higher
O	983	987	than
O	988	992	that
O	993	995	of
O	996	998	MB
O	999	1004	group
O	1004	1005	,
O	1006	1011	which
O	1012	1015	was
B-cv-cont-mean	1016	1017	2
I-cv-cont-mean	1017	1018	.
I-cv-cont-mean	1018	1019	1
O	1020	1021	(
O	1021	1022	P
O	1023	1024	<
O	1025	1026	.
O	1026	1028	05
O	1028	1029	)
O	1029	1030	.

O	1031	1036	There
O	1037	1040	was
O	1041	1043	no
O	1044	1057	statistically
O	1058	1069	significant
O	1070	1080	difference
O	1081	1083	in
B-outcome	1084	1089	false
I-outcome	1090	1098	negative
I-outcome	1099	1103	rate
O	1104	1111	between
O	1112	1120	combined
O	1121	1126	group
O	1127	1130	and
O	1131	1133	MB
O	1134	1139	alone
O	1140	1145	group
O	1145	1146	,
O	1147	1152	which
O	1153	1156	was
B-iv-bin-percent	1157	1158	7
I-iv-bin-percent	1158	1159	.
I-iv-bin-percent	1159	1160	3
I-iv-bin-percent	1160	1161	%
O	1162	1165	and
B-cv-bin-percent	1166	1168	10
I-cv-bin-percent	1168	1169	.
I-cv-bin-percent	1169	1170	5
I-cv-bin-percent	1170	1171	%
O	1171	1172	,
O	1173	1185	respectively
O	1186	1187	(
O	1187	1188	P
O	1189	1190	=
O	1191	1192	.
O	1192	1195	791
O	1195	1196	)
O	1196	1197	.

O	1198	1201	The
O	1202	1210	combined
O	1211	1222	application
O	1223	1225	of
O	1226	1229	ICG
O	1230	1233	and
O	1234	1236	MB
O	1237	1240	for
O	1241	1245	SLNB
O	1246	1248	is
O	1249	1253	much
O	1254	1258	more
O	1259	1268	effective
O	1269	1273	than
O	1274	1276	MB
O	1277	1282	alone
O	1283	1285	in
O	1286	1295	detecting
O	1296	1300	SLNs
O	1300	1301	.
